Media Advisory - Neo Performance Materials Inc. Third Quarter 2024 Earnings Release & Conference Call


Werte in diesem Artikel
Aktien

14.80 EUR -0.20 EUR -1.33 %

TORONTO, Oct. 28, 2024 /CNW/ - Neo Performance Materials Inc. ("Neo" or the "Company") (TSX: NEO) will report its third-quarter results for the period ended September 30, 2024, before the Toronto market opens on Thursday, November 14, 2024.  

Neo Performance Materials Logo (CNW Group/Neo Performance Materials, Inc.)

Teleconference Call

Management will host a teleconference call on Thursday, November 14, 2024 at 10:00 a.m. (Eastern Time) to discuss the third quarter 2024 results.

Interested parties may access the teleconference or webcast. For teleconference, visit https://emportal.ink/47VV4nB or call 1-437-900-0527 (local) or 1-888-510-2154 (toll-free long distance).  For the webcast, visit https://app.webinar.net/v32pRWbDxgQ.

A recording of the teleconference may be accessed by calling (289) 819-1450 (local) or (888) 660-6345 (toll-free long distance) and entering passcode 40961# until December 14, 2024.

About Neo Performance Materials

Neo manufactures the building blocks of many modern technologies that enhance efficiency and sustainability. Neo's advanced industrial materials – magnetic powders and magnets, specialty chemicals, metals, and alloys – are critical to the performance of many everyday products and emerging technologies. Neo's products help to deliver the technologies of tomorrow to consumers today. Neo's business is organized into three segments: Magnequench, Chemicals & Oxides, and Rare Metals.  Neo is headquartered in Toronto, Ontario, Canada; with corporate offices in Greenwood Village, Colorado, United States; Singapore; and Beijing, China. Neo has a global platform that includes ten manufacturing facilities located in Canada, China, Estonia, Germany, Thailand, the United Kingdom, and the United States, as well as one dedicated research and development centre in Singapore.

SOURCE Neo Performance Materials, Inc.

Aktuelle Neogenomics Aktie News

Werbung

Neogenomics Analysen

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Neogenomics nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
Datum Rating Analyst
01.05.19 Neogenomics Buy Needham & Company, LLC
29.03.19 Neogenomics Buy Needham & Company, LLC
03.01.19 Neogenomics Buy Needham & Company, LLC
24.10.18 Neogenomics Strong Buy First Analysis Securities
02.05.18 Neogenomics Equal-Weight First Analysis Securities

Information


Die Handels- und Depotfunktionen in diesem Broker Cockpit werden für Finanzinstrumente von der Finanzen.net Zero GmbH als vertraglich gebundener Vermittler der DonauCapital Wertpapier GmbH (§ 3 Abs. 2 WpIG) bereitgestellt; bei Kryptowerten werden die Handels- und Depotfunktionen in diesem Broker Cockpit ausschließlich von der DonauCapital Wertpapier GmbH bereitgestellt. Die Finanzen.net GmbH stellt ausschließlich den technischen Rahmen bereit und ist in die Wertpapier- und Kryptodienstleistung nicht einbezogen.